5-hydroxymethylcytosine has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, F; Li, Y; Ren, Q; Sun, S; Wang, X; Wu, D; Zhang, M; Zhu, H | 1 |
| Barreiro, LB; Danckaert, A; Dumaine, A; Gicquel, B; Gilad, Y; Grenier, JC; Hansen, KD; He, C; Kobor, MS; Lambourne, J; Luca, F; MacIsaac, JL; Morin, AM; Pacis, A; Pai, A; Pastinen, T; Pique-Regi, R; Tailleux, L; Tung, J; Yotova, V; Yu, M | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and Koch's Disease
| Article | Year |
|---|---|
Combined 5-hydroxymethylcytosine content of human leucocyte antigen-B and human leucocyte antigen-DQB1 as novel biomarker for anti-tuberculosis drug-induced liver injury.
Topics: 5-Methylcytosine; Adult; Antitubercular Agents; Biomarkers; Case-Control Studies; Chemical and Drug Induced Liver Injury; DNA Methylation; Female; Genetic Predisposition to Disease; HLA-B Antigens; HLA-DQ beta-Chains; Humans; Male; Middle Aged; Tuberculosis | 2020 |
Bacterial infection remodels the DNA methylation landscape of human dendritic cells.
Topics: 5-Methylcytosine; Bacterial Infections; CpG Islands; Cytosine; Dendritic Cells; DNA Methylation; Epigenesis, Genetic; Epigenomics; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Mycobacterium tuberculosis; Transcription Factors; Tuberculosis | 2015 |